"Wij zijn Noordwest Ziekenhuisgroep. Een ziekenhuisgroep waarin iedereen samenwerkt aan het zelfde doel: de beste zorg voor onze patiënt. Inwoners van Noordwest-Nederland kunnen bij ons terecht voor uitstekende basiszorg en complexe specialistische zorg. Noordwest Ziekenhuisgroep is ontstaan uit de fusie van Medisch Centrum Alkmaar en het Gemini Ziekenhuis. Al vele jaren bieden beide ziekenhuizen zorg aan de inwoners in Noordwest-Nederland. Met onze nieuwe naam verbinden we ons duidelijk aan deze regio. Onze ambitie is een toonaangevende ziekenhuisgroep te zijn, met een hoge medische standaard én mensgerichte zorg."

During the past decade, Gemini Ziekenhuis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gemini Ziekenhuis" #1 sponsor was "Shire" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Diakonessenhuis, Utrecht" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemini Ziekenhuis" #1 collaborator was "Agendia" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "College of Health Insurances CVZ" with 1 trials as a collaborator, "Dutch Institute for HealthCare Improvement (CBO)" with 1 trials as a collaborator and "Lymphoma Trials Office" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Gemini Ziekenhuis" are "Crohn's Disease" (2 trials), "Breastcancer" (1 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials), "Dyslipidemias" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Gemini Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Gemini Ziekenhuis" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lenalidomide" (2 trials), "Ontamalimab" (2 trials), "Breakthrough collaborative" (1 trials) and "CHOP regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gemini Ziekenhuis" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gemini Ziekenhuis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gemini Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gemini Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".